Regulus Therapeutics Inc (DELISTED) (RGLS:DL)
8.16
0.00 (0.00%)
USD |
NASDAQ |
Jun 30, 16:00
Regulus Therapeutics EPS Diluted (Quarterly): -0.1456 for March 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 1.528 |
| SpringWorks Therapeutics Inc (DELISTED) | -1.111 |
| CorMedix, Inc. | 1.259 |
| BioCardia, Inc. | -0.2362 |
| Xeris Biopharma Holdings, Inc. | 0.0035 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.634M |
| Total Expenses (Quarterly) | 9.634M |
| Enterprise Value | 499.59M |
| Earnings Yield | -8.95% |
| Normalized Earnings Yield | -67.40 |